Do you want to let the FDA know that you support the approval of Ampligen (rintatolimod)? With the final decision now due in less than a month, and an advisory committee recommending against the drug, advocates have put together a petition to show the FDA how badly people with chronic fatigue syndrome want this drug on the market.
Currently, no drugs are FDA-approved for chronic fatigue syndrome. This is Ampligen's second attempt at approval, and while experts believe several factors make approval more likely this time, the advisory committee's decision is hanging ominously out there.
You can read and sign the petition here:
Are you in favor of approval? Why or why not? Have you tried Ampligen? Leave your comments below!